Abnova (Taiwan) (TPE:4133) Cyclically Adjusted Revenue per Share: NT$8.23 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4133 Abnova (Taiwan) Corp TPE:4133
75 GF Score
Price NT$22.70
GF Value NT$28.19
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Abnova (Taiwan) Cyclically Adjusted Revenue per Share?

Abnova (Taiwan) TPE:4133 +4.85% 75 Cyclically Adjusted Revenue per Share is NT$8.23 as of Dec. 2025. GuruFocus rates TPE:4133 with a GF Score™ of 75/100 and a GF Value™ of NT$28.19 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Abnova (Taiwan)'s adjusted revenue per share for the three months ended in Dec. 2025 was NT$1.386. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$8.23 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Abnova (Taiwan)'s average Cyclically Adjusted Revenue Growth Rate was -2.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -1.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Abnova (Taiwan) was 2.40% per year. The lowest was -1.50% per year. And the median was 1.40% per year.

As of today (2026-07-24), Abnova (Taiwan)'s current stock price is NT$22.70. Abnova (Taiwan)'s Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was NT$8.23. Abnova (Taiwan)'s Cyclically Adjusted PS Ratio of today is 2.76.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abnova (Taiwan) was 19.07. The lowest was 2.46. And the median was 4.00.


Abnova (Taiwan)  (TPE:4133) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abnova (Taiwan)'s Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=22.70/8.23
=2.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abnova (Taiwan) was 19.07. The lowest was 2.46. And the median was 4.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Abnova (Taiwan) Cyclically Adjusted Revenue per Share Related Terms


Abnova (Taiwan) Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Abnova (Taiwan)'s Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abnova (Taiwan) Cyclically Adjusted Revenue per Share Chart

Abnova (Taiwan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.35 8.61 8.55 8.44 8.23

Abnova (Taiwan) Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.44 8.45 8.41 8.37 8.23

TPE:4133 vs VRTX, REGN, ALNY: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Abnova (Taiwan)'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abnova (Taiwan) Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abnova (Taiwan)'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abnova (Taiwan)'s Cyclically Adjusted PS Ratio falls into.


TPE:4133
75GF Score
Abnova (Taiwan) Corp TPE:4133
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abnova (Taiwan) Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abnova (Taiwan)'s adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=1.386/324.0540*324.0540
=1.386

Current CPI (Dec. 2025) = 324.0540.

Abnova (Taiwan) Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 1.942 238.132 2.643
201606 1.802 241.018 2.423
201609 1.804 241.428 2.421
201612 1.758 241.432 2.360
201703 1.973 243.801 2.622
201706 2.012 244.955 2.662
201709 2.028 246.819 2.663
201712 1.839 246.524 2.417
201803 1.803 249.554 2.341
201806 1.856 251.989 2.387
201809 1.722 252.439 2.211
201812 1.590 251.233 2.051
201903 1.793 254.202 2.286
201906 1.655 256.143 2.094
201909 1.814 256.759 2.289
201912 1.706 256.974 2.151
202003 1.650 258.115 2.072
202006 1.755 257.797 2.206
202009 2.237 260.280 2.785
202012 1.970 260.474 2.451
202103 1.887 264.877 2.309
202106 1.976 271.696 2.357
202109 1.946 274.310 2.299
202112 1.600 278.802 1.860
202203 1.637 287.504 1.845
202206 1.692 296.311 1.850
202209 1.664 296.808 1.817
202212 1.781 296.797 1.945
202303 1.574 301.836 1.690
202306 1.640 305.109 1.742
202309 1.572 307.789 1.655
202312 1.551 306.746 1.639
202403 1.402 312.332 1.455
202406 1.505 314.175 1.552
202409 1.450 315.301 1.490
202412 1.450 315.605 1.489
202503 1.493 319.799 1.513
202506 1.494 322.561 1.501
202509 1.412 324.800 1.409
202512 1.386 324.054 1.386

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$8.23 mean?
Abnova (Taiwan) (TPE:4133) has a Cyclically Adjusted Revenue per Share of NT$8.23 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Abnova (Taiwan) and its competitors.
Is Abnova (Taiwan)'s Cyclically Adjusted Revenue per Share too high?
Abnova (Taiwan)'s current Cyclically Adjusted Revenue per Share is NT$8.23. Overall, Abnova (Taiwan) has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abnova (Taiwan)'s Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Abnova (Taiwan)'s Cyclically Adjusted Revenue per Share of NT$8.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Abnova (Taiwan) and its competitors. Abnova (Taiwan)'s current Cyclically Adjusted Revenue per Share is NT$8.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abnova (Taiwan) stock overvalued right now?
Based on GuruFocus' analysis, Abnova (Taiwan) (TPE:4133) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$28.19, compared to a current price of NT$22.70 — trading 19.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$8.23. Abnova (Taiwan)'s overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Abnova (Taiwan) (TPE:4133), the current Cyclically Adjusted Revenue per Share is NT$8.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abnova (Taiwan) (TPE:4133) Overvalued in 2026?

Based on GuruFocus' analysis, Abnova (Taiwan) stock appears to be undervalued. The current stock price of NT$22.70 is trading 19.5% below its estimated GF Value™ of NT$28.19. GuruFocus considers Abnova (Taiwan) to be Modestly Undervalued.

Key valuation signals for TPE:4133:

  • Cyclically Adjusted Revenue per Share: NT$8.23
  • GF Value™: NT$28.19 vs. price of NT$22.70 (19.5% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the TPE:4133 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abnova (Taiwan) Business Description

Address No.108, Jhouzih Street, 9th Floor, Neihu District, Taipei City, TWN
Abnova (Taiwan) Corp is engaged in developing, manufacturing, and selling monoclonal antibody, polyclonal antibody, proteins, medical inspection instruments and testing reagents, which are mainly antibody reagents, antibody chips or related products provided to and used by academic, research institutions or pharmaceutical factories. Geographically, it operates in America, Europe, Taiwan and Other Countries. It generates maximum revenue from America. Its products include: SARS-CoV/CoV-2, DNA, RNA new, Proteins/peptides, MaxPab, DNAxPab, Polyclonal Ab, Monoclonal Ab and Others. The company's services are: Gene synthesis & cytogenetics, Peptide services, Protein expression, Humanized antibody, Assay development, Conjugation, FFPE tumor tissue DNA, In situ hybridization (ISH) and Others.
75GF Score

Get the complete analysis for TPE:4133

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.70
Price
NT$28.19
GF Value